L&G Healthcare Technology & Innovation ETF USD Acc (DOCG)

Category Sector Equity Healthcare

star-filled
This ETF can be held in an Investment ISA, SIPP and Investment Account
Sell

836.70p

Buy

839.60p

arrow-down-2.60p (-0.31%)

Prices updated at 30 May 2025, 15:13 BST
| Prices minimum 15 mins delay
|
Prices in GBX

Investment objective
The investment objective of the Fund is to provide exposure to the global healthcare technology industry. In order to achieve this investment objective, the Fund will seek to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the “Index”). It will do so by investing primarily in a portfolio of equity securities that, as far as possible and practicable, consists of the component securities of the Index in similar proportions to their weightings in the Index and may have exposure to or invest directly up to 20% of its Net Asset Value in shares issued by the same body, which limit may be raised to 35% for a single issuer in exceptional market conditions, including (but not limited to) circumstances in which such issuer occupies a dominant market position.

arrow-up0.58%
LSE

Important notice: This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Please refer to the FCA website which details further information in relation to sustainability disclosure requirements for retail clients.

Portfolio as of 29/05/2025

Asset allocation

Created with Highcharts 7.2.299.86% Stocks- Bonds0.14% Cash- Other0% Not classified
Show long & short position

Geographical breakdown

Continent or country allocation (%)

Created with Highcharts 7.2.20.980.981.351.351.781.784.964.966.696.6984.2584.25JapanUnited KingdomAsia - EmergingEurope - ex EuroEurozoneUnited States

Market classification (%)

Created with Highcharts 7.2.21.781.7898.2298.22EmergingDeveloped

Stock style

Medium core

20.25%

% Weight
Value
Core
Growth
Large

6

10

6

Medium

6

20

9

Small

10

15

17

Valuation

L&G Healthcare Technology & Innovation ETF USD Acc
Sector Equity Healthcare

20.39

20.39
19.28

3.28

3.28
1.89

3.16

3.16
4.37

13.95

13.95
15.75

Growth rate

L&G Healthcare Technology & Innovation ETF USD Acc
Sector Equity Healthcare

7.08%

7.08%
9.97%

0.43%

0.43%
1.38%

-2.80%

-2.80%
3.52%

Top 10 holdings

Security nameSectorCountry% of assets
1Alnylam Pharmaceuticals Inc-United States2.45
2Natera Inc-United States2.30
3Intuitive Surgical Inc-United States2.19
4iRhythm Technologies Inc-United States2.19
5Boston Scientific Corp-United States2.16
6Artivion Inc-United States2.11
7Stryker Corp-United States2.06
8Tempus AI Inc Class A common stock-United States2.04
9Eurofins Scientific SE-Luxembourg2.01
10Guardant Health Inc-United States2.01
Assets in top 10 holdings %

21.52%

Total no. of equity holdings

63.00

Total no. of bond holdings

-

Stock sectors

L&G Healthcare Technology & Innovation ETF USD Acc
Sector Equity Healthcare

0.00%

Basic materials

-
-

Con cyclical

-
-

Financial svs

-
-

Real estate

-
-

1.47%

Comm services

-
-

Energy

-
-

Industrials

-
-

Technology

1.47%
-

98.53%

Con defensive

-
-

Healthcare

98.53%
-

Utilities

-
-


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2025 Morningstar. All rights reserved.